Scott Juda insider trades
Open-market stock purchases and sales by Scott Juda, Director at Inmune Bio, Inc, from SEC Form 4 filings since Jun 3, 2019.
Track record: 0% of 6 scored buys are up 5% or more since purchase, averaging -78%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jul 2, 2026 | INMB Inmune Bio, Inc | Bought (not open market) | $20.7K |
| Jul 2, 2026 | INMB Inmune Bio, Inc | Bought (not open market) | $1.9K |
| Dec 1, 2025 | INMB Inmune Bio, Inc | Bought (not open market) | — |
| Nov 18, 2025 | INMB Inmune Bio, Inc | Sold (not open market) | $333K |
| Nov 18, 2025 | INMB Inmune Bio, Inc | Bought (not open market) | $52.5K |
| Nov 18, 2025 | INMB Inmune Bio, Inc | Sold (not open market) | $164K |
| Nov 18, 2025 | INMB Inmune Bio, Inc | Sold (not open market) | $422K |
| Nov 18, 2025 | INMB Inmune Bio, Inc | Bought (not open market) | $162K |
| Nov 18, 2025 | INMB Inmune Bio, Inc | Sold (not open market) | $396K |
| Nov 18, 2025 | INMB Inmune Bio, Inc | Bought (not open market) | $24K |
| Nov 18, 2025 | INMB Inmune Bio, Inc | Bought (not open market) | $28.5K |
| Nov 18, 2025 | INMB Inmune Bio, Inc | Sold (not open market) | $341K |
| Nov 18, 2025 | INMB Inmune Bio, Inc | Bought (not open market) | $48.8K |
| Nov 18, 2025 | INMB Inmune Bio, Inc | Sold (not open market) | $124K |
| Nov 18, 2025 | INMB Inmune Bio, Inc | Bought (not open market) | $18.8K |
Companies traded
- INMB Inmune Bio, Inc: 7 buys, last Jul 2, 2026